Wednesday, June 02, 2021 12:05:39 PM
NRXP valuation $1.5B/RLF $700M? Complicated Data analysis Presentation to FDA as .
JJ and Daniel own 60% of NRXP and with any approval get much more. THEY've been PAID, WTF do they care anymore. Hypocritic oath, health of Others? Greed/malfeasance/stupidity has dragged this out too long. Only a few have profited, common shareholders have been phukt and even Flipping/holding their Stocks for pennies/a buildout/more CTs for further indications, A REAL WORLD PARTNERSHIP with A BIG PHARMA Etc? Time has cost me/us Money.
Maybe an EMA application will get some Priority there. Finally some acknowledgement of patent holder RLF by NRXP but has the delay been overpowering?
JJ should have let the CT Run/Complete instead of HIS FUBARS with the FDA. We will see IF HE/THEY have earned respect from the FDA or just PO'ed them.
Decreasing Volume @ both *+*.
Time has cost me/us Money. Are they really competing still? Is there hope for the DPA with McMaster and the formulation for extended shelf life. Dry film or Inhaled?
https://www.investors.com/news/technology/pfizer-stock-buy-now/?src=A00220
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM